Jeffrey S Barrett

A Modeling and Simulations Framework to Support Global Regulatory Strategies for Pediatric Drug Development Programs

Jean-Francois Marier, Barry Mangum, Betsy Reid, 2013, Therapeutic innovation & regulatory science.

Time to Expect More From Pharmacometrics

Jeffrey S Barrett, J. Barrett, 2020, Clinical pharmacology and therapeutics.

Perspective on Data‐Sharing Requirements for the Necessary Evolution of Drug Development

Jeffrey S Barrett, 2020, Journal of clinical pharmacology.

Key performance indicators for the assessment of pediatric pharmacotherapeutic guidance.

Jeffrey S Barrett, Mahesh Narayan, Bhuvana Jayaraman, 2008, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

Potent obatoclax cytotoxicity and activation of triple death mode killing across infant acute lymphoblastic leukemia.

Kajia Cao, Mondira Kundu, Li-San Wang, 2013, Blood.

Shortening the timeline of pediatric phase I trials: the rolling six design.

Jeffrey S Barrett, Bhuvana Jayaraman, J. Barrett, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacometrics: A Multidisciplinary Field to Facilitate Critical Thinking in Drug Development and Translational Research Settings

Marc R Gastonguay, Jeffrey S Barrett, Michael J Fossler, 2008, Journal of clinical pharmacology.

Model-based drug development applied to oncology

Jeffrey S Barrett, J. Barrett, Manish Gupta, 2007, Expert opinion on drug discovery.